Guided Therapeutics Inc. Stock Analysis GTHP
Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. The company is headquartered in Norcross, Georgia and currently employs 4 full-time employees. The firm is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Read More Guided Therapeutics Inc (GTHP) Chart
Key Statistics of Guided Therapeutics Inc (GTHP)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.21Volume
23.38KP/E Ratio (TTM)
-52 Week Range
Market Cap
19.27MAvg. Volume
28.01KDividend Yield
-Financial Metrics & Statements of Guided Therapeutics Inc (GTHP)
FAQ's for Guided Therapeutics Inc (GTHP)
- According to Musaffa’s Shariah screening methodology, Guided Therapeutics Inc (GTHP) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.